GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLA) » Definitions » Days Inventory

Estrella Immunopharma (Estrella Immunopharma) Days Inventory : 0.00 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Estrella Immunopharma's Average Total Inventories for the three months ended in Mar. 2024 was $0.00 Mil. Estrella Immunopharma's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.00 Mil.

The historical rank and industry rank for Estrella Immunopharma's Days Inventory or its related term are showing as below:

ESLA's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 193.29
* Ranked among companies with meaningful Days Inventory only.

Estrella Immunopharma's Days Inventory stayed the same from Dec. 2022 (0.00) to Mar. 2024 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Estrella Immunopharma Days Inventory Historical Data

The historical data trend for Estrella Immunopharma's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Estrella Immunopharma Days Inventory Chart

Estrella Immunopharma Annual Data
Trend Jun21
Days Inventory
-

Estrella Immunopharma Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Estrella Immunopharma's Days Inventory

For the Biotechnology subindustry, Estrella Immunopharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Estrella Immunopharma's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Estrella Immunopharma's Days Inventory distribution charts can be found below:

* The bar in red indicates where Estrella Immunopharma's Days Inventory falls into.



Estrella Immunopharma Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Estrella Immunopharma's Days Inventory for the fiscal year that ended in Jun. 2021 is calculated as

Days Inventory (A: Jun. 2021 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: . 20 ) + Total Inventories (A: Jun. 2021 )) / count ) / Cost of Goods Sold (A: Jun. 2021 )*Days in Period
=( ( + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Estrella Immunopharma's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:

Days Inventory (Q: Mar. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Estrella Immunopharma  (NAS:ESLA) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Estrella Immunopharma's Inventory Turnover for the three months ended in Mar. 2024 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Estrella Immunopharma's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Estrella Immunopharma Days Inventory Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Estrella Immunopharma (Estrella Immunopharma) Business Description

Traded in Other Exchanges
N/A
Address
5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma (Estrella Immunopharma) Headlines

No Headlines